رجوع
60
نطاق اليوم
KWD 39.56
KWD 42.68
نطاق 52 أسبوعًا
KWD 39.56
KWD 42.68
حجم التداول
476
متوسط 50 يوم / 200 يوم
KWD 39.56
/
KWD 39.56
الإغلاق السابق
KWD 39.56
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (626 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 18.7 | 0.4 |
| P/B | 3.5 | 2.9 |
| ROE % | 19.9 | 3.7 |
| Net Margin % | 9.6 | 3.9 |
| Rev Growth 5Y % | 10.4 | 10.0 |
| D/E | 1.6 | 0.2 |
السعر المستهدف للمحللين
لا تتوفر تغطية محللين
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2029 |
KWD 0.000
KWD 0.000 – KWD 0.000
|
1.3 B | 0 |
| FY2028 |
KWD 3.336
KWD 3.276 – KWD 3.390
|
1.3 B | 1 |
| FY2027 |
KWD 2.557
KWD 2.511 – KWD 2.598
|
1.3 B | 1 |
النقاط الرئيسية
Revenue grew 10.44% annually over 5 years — strong growth
Earnings grew 82.44% over the past year
ROE of 19.90% — decent returns on equity
Generating 163.14M in free cash flow
PEG of 0.24 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 7.83%
النمو
Revenue Growth (5Y)
10.44%
Revenue (1Y)2.61%
Earnings (1Y)82.44%
FCF Growth (3Y)-19.14%
الجودة
Return on Equity
19.90%
ROIC10.27%
Net Margin9.64%
Op. Margin18.37%
الأمان
Debt / Equity
1.62
Current Ratio1.82
Interest Coverage3.71
التقييم
P/E Ratio
18.72
P/B Ratio3.52
EV/EBITDA13.78
Dividend Yield0.02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 2.61% | Revenue Growth (3Y) | 7.34% |
| Earnings Growth (1Y) | 82.44% | Earnings Growth (3Y) | -7.93% |
| Revenue Growth (5Y) | 10.44% | Earnings Growth (5Y) | 7.30% |
| Profitability | |||
| Revenue (TTM) | 1.18B | Net Income (TTM) | 113.79M |
| ROE | 19.90% | ROA | 5.47% |
| Gross Margin | 64.96% | Operating Margin | 18.37% |
| Net Margin | 9.64% | Free Cash Flow (TTM) | 163.14M |
| ROIC | 10.27% | FCF Growth (3Y) | -19.14% |
| Safety | |||
| Debt / Equity | 1.62 | Current Ratio | 1.82 |
| Interest Coverage | 3.71 | Dividend Yield | 0.02% |
| Valuation | |||
| P/E Ratio | 18.72 | P/B Ratio | 3.52 |
| P/S Ratio | 1.80 | PEG Ratio | 0.24 |
| EV/EBITDA | 13.78 | Dividend Yield | 0.02% |
| Market Cap | 2.13B | Enterprise Value | 2.99B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 1.18B | 1.15B | 1.02B | 942.91M | 793.83M |
| Net Income | 113.79M | 62.37M | 134.24M | 209.58M | 85.83M |
| EPS (Diluted) | 2.11 | 1.16 | 2.49 | 3.89 | 1.59 |
| Gross Profit | 767.07M | 704.14M | 660.83M | 620.69M | 463.48M |
| Operating Income | 216.93M | 182.89M | 243.69M | 298.47M | 136.85M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 2.08B | 2.16B | 1.41B | 1.41B | 1.22B |
| Total Liabilities | 1.47B | 1.62B | 880.34M | 907.14M | 899.81M |
| Shareholders' Equity | 604.42M | 539.21M | 531.59M | 497.32M | 321.97M |
| Total Debt | 979.61M | 1.08B | 516.45M | 580.30M | 606.80M |
| Cash & Equivalents | 121.20M | 158.72M | 149.92M | 160.32M | 120.62M |
| Current Assets | 593.50M | 630.50M | 533.95M | 519.22M | 400.05M |
| Current Liabilities | 326.92M | 394.49M | 217.79M | 155.61M | 132.87M |
درجات الاستراتيجيات
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Growth + Value
Growth at a Reasonable Price (Peter Lynch)
#93 of 326
النشاط الأخير
دخل
Growth at a Reasonable Price (Peter Lynch)
Mar 24, 2026